Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000939
Chunk: 55

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 55
---
 suspension;

(c) the
delisting of the Depositary Shares from The Nasdaq Capital Market (or any nationally recognized successor thereto), unless the Depositary
Shares are then immediately thereafter trading on The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange,
the NYSE American, the NYSE Arca, or the OTCQX or OTCQB operated by the OTC Markets Group, Inc. (or any nationally recognized successors
thereto);

| -29- |

(d) the
failure for any reason by the Depositary to issue Purchase Shares to the Investor on the Business Days on which the Investor is entitled
to receive such Purchase Shares;

(e) the
Company breaches any representation, warranty, covenant or other term or condition under any Transaction Document if such breach would
reasonably be expected to have a Material Adverse Effect and except, in the case of a breach of a covenant which is reasonably curable,
only if such breach continues for a period of at least ten (10) consecutive Business Days;

(f) if
any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law and such proceeding is not
dismissed;

(g) if
the Company, pursuant to or within the meaning of any Bankruptcy Law, (i) commences a voluntary case, (ii) consents to the entry of an
order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially
all of its property, or (iv) makes a general assignment for the benefit of its creditors or is generally unable to pay its debts as the
same become due;

(h) a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against the Company in an involuntary
case, (ii) appoints a Custodian of the Company or for all or substantially all of its property, or (iii) orders the liquidation of the
Company for so long as such order, decree or similar action remains in effect;

(i) if
at any time the Company is not eligible to transfer its Depositary Shares electronically as DWAC Shares; or

(j) if
at any time after the Commencement Date, an event has occurred that has had a Material Adverse Effect.

In addition to any other rights and remedies under
applicable law and this Agreement, so long as a Suspension Event has occurred and